Pediatr Transplant 2021 Aug
Treatment of post-transplant lymphoproliferative disorder (PTLD) in a heart transplant recipient with chimeric antigen receptor T-cell therapy.
Related Questions
New answer by at University of Nebraska Medical Center (January 1, 2024)
The short version of my answer is: Possibly Yes. There is a very limited evidence from the literature in this topic, however, I will base my explanation on the following ...